Literature DB >> 22283901

Hepatitis C virus infection in patients with tuberculosis in Central Brazil.

N R S Reis1, C L R Lopes, S A Teles, M A D Matos, M A S Carneiro, T A Marinho, J A Araújo Filho, M P Espírito-Santo, E Lampe, R M B Martins.   

Abstract

SETTING: Goiânia City, Goiás State, Brazil.
OBJECTIVES: To determine the prevalence of hepatitis C virus (HCV) infection, risk factors, HCV genotype/ subtype, HCV viral load and human immunodeficiency virus (HIV) status in patients with tuberculosis (TB) in Central Brazil.
DESIGN: A cross-sectional study was carried out with 402 patients who were under tuberculosis (TB) treatment in the reference hospital for infectious diseases in Goiânia, Goiás, Central Brazil.
RESULTS: The prevalence rates of HCV and HIV were respectively 7.5% and 27.6%. Two thirds of the HCV-infected patients (20/30) were HIV-positive. Age, injecting drug use (IDU) and HIV status were factors independently associated with HCV infection. HCV RNA was detected in 23 serum samples; HCV RNA levels were measured in 22/23 samples. HCV RNA level was slightly higher in HCV-HIV co-infected patients than in HCV monoinfected patients. Genotypes 1 (n = 17) and 3 (n = 6) were determined by LiPA. Using phylogenetic tree analysis of the NS5B region, subtypes 1a (n = 12), 1b (n = 2) and 3a (n = 6) were identified.
CONCLUSION: These data indicate that patients with TB may benefit from integrated HIV and HCV screening, which may have an important impact upon TB management and treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22283901     DOI: 10.5588/ijtld.10.0636

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  11 in total

Review 1.  A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment.

Authors:  Russell R Kempker; Wael A Alghamdi; Mohammad H Al-Shaer; Gena Burch; Charles A Peloquin
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

2.  Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010.

Authors:  G Bushnell; N L Stennis; A M Drobnik; D C Proops; S D Ahuja; K Bornschlegel; J Fuld
Journal:  Epidemiol Infect       Date:  2014-11-12       Impact factor: 4.434

3.  Prevalence of hepatitis C virus and human immunodeficiency virus in a group of patients newly diagnosed with active tuberculosis in Porto Alegre, Southern Brazil.

Authors:  Cintia Costi; Tarciana Grandi; Maria Laura Halon; Márcia Susana Nunes Silva; Cláudia Maria Dornelles da Silva; Tatiana Schäffer Gregianini; Lia Gonçalves Possuelo; Carla Adriane Jarczewski; Christian Niel; Maria Lucia Rosa Rossetti
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-04       Impact factor: 2.743

4.  Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan.

Authors:  Sabrina Hermosilla; Paul You; Angela Aifah; Tleukhan Abildayev; Ainur Akilzhanova; Ulan Kozhamkulov; Talgat Muminov; Meruert Darisheva; Baurzhan Zhussupov; Assel Terlikbayeva; Nabila El-Bassel; Neil Schluger
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

5.  Impacts of hepatitis B and hepatitis C co-infection with tuberculosis, a prospective cohort study.

Authors:  Berhanu Elfu Feleke; Teferi Elfu Feleke; Wondimu Gebrekiros Adane; Abel Girma
Journal:  Virol J       Date:  2020-07-23       Impact factor: 4.099

6.  Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.

Authors:  Marco Antonio Moreira Puga; Larissa Melo Bandeira; Mauricio Antonio Pompilio; Grazielli Rocha de Rezende; Luana Silva Soares; Vivianne de Oliveira Langraf de Castro; Tayana Serpa Ortiz Tanaka; Gabriela Alves Cesar; Sandra Maria do Valle Leone de Oliveira; Sheila Araújo Teles; Renata Terumi Shiguematsu Yassuda; Sabrina Moreira Dos Santos Weis-Torres; Sarlete Ferreira Basílio; Julio Croda; Ana Rita Coimbra Motta-Castro
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

7.  Characterization of hepatitis C infection in tuberculosis patients in an urban city in the USA.

Authors:  M Campo; A Shrestha; E Oren; H Thiede; J Duchin; M Narita; K Crothers
Journal:  Epidemiol Infect       Date:  2013-09-25       Impact factor: 4.434

8.  Prevalence of Hepatitis C Virus in Tuberculosis Patients: A Systematic Review and Meta-Analysis.

Authors:  Meysam Behzadifar; Sanaz Heydarvand; Masoud Behzadifar; Nicola Luigi Bragazzi
Journal:  Ethiop J Health Sci       Date:  2019-01

9.  Hepatitis C Virus Affects Tuberculosis-Specific T Cells in HIV-Negative Patients.

Authors:  Mohamed Ahmed El-Mokhtar; Sherein G Elgendy; Abeer Sharaf Eldin; Elham Ahmed Hassan; Ali Abdel Azeem Hasan; Muhamad R Abdel Hameed; Douaa Sayed; Eman H Salama
Journal:  Viruses       Date:  2020-01-15       Impact factor: 5.048

10.  Hepatitis C Virus Infection Is Associated With an Increased Risk of Active Tuberculosis Disease: A Nationwide Population-Based Study.

Authors:  Ping-Hsun Wu; Yi-Ting Lin; Kun-Pin Hsieh; Hung-Yi Chuang; Chau-Chyun Sheu
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.